Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RTS Life Sciences to Produce Robotic Blood System

By HospiMedica staff writers
Posted on 17 Apr 2006
RTS Life Sciences (Manchester, UK) has won a contract to design and install an automated robotic system incorporating machine vision for the new UK Biobank (Cheadle, UK).

The contract follows the development of a prototype vision system by the company. More...
The full fractionation system will be commissioned in the second quarter of 2006, by which time it will be fully integrated with Biobank's software and database.

The UK Biobank aims to build a major resource to support research that will improve the prevention, diagnosis, and treatment of illness and promote health throughout society. The project will follow the health of 500,000 volunteers for up to 30 years, collecting information on environment and lifestyle factors, and linking these to medical records and biologic samples.

Paul Downey, director of laboratory operations at the UK Biobank, explained that the research would require approximately 3,500 samples of blood to be processed each day. In addition to the large number of technicians this output would require, there are the serious health aspects of exposing people to such large amounts of unscreened blood.

When blood is centrifuged at low speeds, it separates into three fractions: plasma, the buffy coat containing the white blood cells, and erythrocytes. The RTS system centrifuges the blood into individual containers, identifies each sample, identifies the fractions, and aliquots the chosen fraction into arrays of 96 x1 ml tubes. A digital camera takes two images and software analyzes the images to determine the exact boundaries between the layers. The layers are then converted into liquid handling protocols and mapped to destination tubes before the robot aliquots the layers into tubes prior to storage or preparation for assays.

The UK Biobank will collect and store all fractions of blood as each fraction can reveal something different about an individual's health, and because more detailed assays will be developed in the future.



Related Links:
RTS Life Sciences
UK Biobank

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.